Characterization of a New Endometrial Carcinoma Cell Line EN-1078D
Author Information
Author(s): Dery Marie-Claude, Van Themsche Celine, Provencher Diane, Mes-Masson Anne-Marie, Asselin Eric
Primary Institution: Université du Québec à Trois-Rivières
Hypothesis
The study aims to characterize the EN-1078D cell line to understand its properties related to endometrial cancer metastasis.
Conclusion
The EN-1078D cell line is a valuable tool for studying metastatic endometrial cancer due to its tumorigenic properties and sensitivity to chemotherapy.
Supporting Evidence
- EN-1078D cells express both estrogen receptor isoforms and low levels of progesterone receptor B.
- All nude mice developed tumors after subcutaneous injections of EN-1078D cells.
- EN-1078D cells showed sensitivity to cisplatin and doxorubicin with specific IC50 values.
Takeaway
Researchers created a new cell line from a type of cancer to learn more about how it spreads and how to treat it better.
Methodology
The study involved cytological, molecular, and in vivo assays to characterize the EN-1078D cell line and its response to chemotherapy.
Potential Biases
Potential bias in the interpretation of results due to the use of a single cell line and specific experimental conditions.
Limitations
The study primarily focuses on a single cell line, which may not represent all endometrial carcinoma types.
Participant Demographics
The cell line was derived from a 52-year-old woman with poorly differentiated endometrial adenocarcinoma.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website